Neutra SEC Filings

Type
Report
Date
15-12G15-12G-Formular12/12/2024
10-QQuartalsbericht8/7/2024
10-KJahresbericht8/2/2024
NT 10-QNT 10-Q-Formular6/17/2024
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben5/15/2024
NT 10-KNT 10-K-Formular4/30/2024
10-QQuartalsbericht12/15/2023
10-QQuartalsbericht9/14/2023
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben8/4/2023
10-QQuartalsbericht6/22/2023
10-KJahresbericht6/9/2023
NT 10-KNT 10-K-Formular5/1/2023
10-QQuartalsbericht12/15/2022
10-QQuartalsbericht9/14/2022
10-QQuartalsbericht6/21/2022
NT 10-QNT 10-Q-Formular6/14/2022
10-KJahresbericht5/10/2022
NT 10-KNT 10-K-Formular5/2/2022
10-QQuartalsbericht12/10/2021
10-QQuartalsbericht9/14/2021
10-QQuartalsbericht6/21/2021
NT 10-QNT 10-Q-Formular6/14/2021
10-K/A10-K/A-Formular5/19/2021
10-KJahresbericht5/17/2021
NT 10-KNT 10-K-Formular5/3/2021
10-QQuartalsbericht12/21/2020
NT 10-QNT 10-Q-Formular12/16/2020
10-Q/A10-Q/A-Formular9/22/2020
10-QQuartalsbericht9/14/2020
10-Q/A10-Q/A-Formular7/17/2020
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben7/16/2020
10-QQuartalsbericht7/14/2020
10-K/A10-K/A-Formular6/29/2020
10-KJahresbericht6/24/2020
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben6/15/2020
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben4/30/2020
10-Q/A10-Q/A-Formular1/9/2020
10-QQuartalsbericht12/23/2019
NT 10-QNT 10-Q-Formular12/16/2019
UPLOADUPLOAD-Formular10/18/2019
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben10/11/2019
CORRESPCORRESP-Formular10/10/2019
UPLOADUPLOAD-Formular10/7/2019
10-Q/A10-Q/A-Formular9/26/2019
PRE 14CPRE 14C-Formular9/24/2019
10-QQuartalsbericht9/23/2019
NT 10-QNT 10-Q-Formular9/17/2019
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben9/6/2019
10-Q/A10-Q/A-Formular6/18/2019
10-QQuartalsbericht6/14/2019
10-K/A10-K/A-Formular5/6/2019
10-KJahresbericht5/1/2019
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben4/29/2019
RWRW-Formular3/18/2019
10-Q/A10-Q/A-Formular1/7/2019
SC 13DSC 13D-Formular12/28/2018
10-QQuartalsbericht12/17/2018
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben10/2/2018
10-Q/A10-Q/A-Formular9/18/2018
10-QQuartalsbericht9/14/2018
EFFECTEFFECT-Formular8/27/2018
CORRESPCORRESP-Formular8/23/2018
S-1/AS-1/A-Formular8/13/2018
UPLOADUPLOAD-Formular8/6/2018
S-1/AS-1/A-Formular7/25/2018
10-Q/A10-Q/A-Formular6/18/2018
10-QQuartalsbericht6/14/2018
UPLOADUPLOAD-Formular6/14/2018
NT 10-QNT 10-Q-Formular6/14/2018
S-1S-1-Formular5/21/2018
10-KJahresbericht5/1/2018
SC 13GSC 13G-Formular1/16/2018
10-QQuartalsbericht12/20/2017
NT 10-QNT 10-Q-Formular12/18/2017
10-Q/A10-Q/A-Formular9/26/2017
10-QQuartalsbericht9/19/2017
NT 10-QNT 10-Q-Formular9/14/2017
S-8 POSS-8 POS-Formular7/7/2017
10-QQuartalsbericht6/14/2017
10-K/A10-K/A-Formular5/22/2017
10-KJahresbericht5/17/2017
NT 10-KNT 10-K-Formular5/2/2017
10-QQuartalsbericht1/31/2017
10-Q/A10-Q/A-Formular1/13/2017
10-Q/A10-Q/A-Formular1/13/2017
NT 10-QNT 10-Q-Formular12/16/2016
10-QQuartalsbericht10/17/2016
10-QQuartalsbericht8/8/2016
10-K/A10-K/A-Formular6/16/2016
NT 10-QNT 10-Q-Formular6/15/2016
10-KJahresbericht5/17/2016
NT 10-KNT 10-K-Formular5/3/2016
S-1/AS-1/A-Formular3/8/2016
S-1S-1-Formular2/16/2016
10-QQuartalsbericht12/21/2015
NT 10-QNT 10-Q-Formular12/16/2015
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben9/16/2015
10-QQuartalsbericht9/14/2015
DEF 14ADEF 14A-Formular8/11/2015
PRE 14APRE 14A-Formular7/31/2015

Neutra Documents 2026

This page contains all official documents and SEC filings for Neutra stock (NTRR, ISIN: US64129C3034). This includes annual reports (Form 10-K), quarterly reports (Form 10-Q), and insider transactions (Form 4). Currently 100 documents are available. Data is updated regularly to provide investors with a complete overview of Neutra's regulatory filings.

Neutra Stock analysis

Neutra Neutra Corp, headquartered in Sugar Land, Texas, focuses on research and development of modern healthy living solutions within the nutraceutical sector. The company specializes in hemp-derived products, including those containing delta-8-THC and other cannabinoids, primarily targeting the medical cannabis market. Neutra Corp markets its branded products through private-label manufacturing partnerships, with subsidiaries such as Diamond Anvil Designs, LLC, Deity Corporation, and Vivis Corporation operating in the nutraceutical space.